Concepedia

Oral estramustine and oral etoposide for hormone-refractory prostate cancer

Meletios Α. Dimopoulos, C Panopoulos, Christina Bamia, C. Deliveliotis, C. Constantinidis, A. Kostakopoulos, Ioannis Kastriotis, Anastasios Zervas, Gerasimos Aravantinos, C Dimopoulos

Urology · 1997 · 80 citations · 14 references

DOI

Concepts

References

14

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 7.8K citations

, , +10

Evaluation of survival data and two new rank order statistics arising in its consideration.

Nathan Mantel · PubMed · 1966 · 7.6K citations

, , +11

Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.

Howard I. Scher, William Kevin Kelly · Journal of Clinical Oncology · 1993 · 413 citations

, , +17

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.

William Kevin Kelly, Howard I. Scher, Madhu Mazumdar et al. · Journal of Clinical Oncology · 1993 · 389 citations

, , +13

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.

G. R. Hudes, Richard E. Greenberg, Robert L. Krigel et al. · Journal of Clinical Oncology · 1992 · 256 citations

, , +16